Formononetin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-03884 |
| CAS | 485-72-3 |
| Molecular Weight | 268.26 |
| Molecular Formula | C16H12O4 |
| Purity | >98% |
Ordering Information
| Catalog Number | Size | Price | Stock | Quantity |
|---|---|---|---|---|
| BBF-03884 | 5 g | $269 | In stock |
Online Inquiry
Add to cartDescription
Formononetin is a phytoestrogen from the root of Astragalus membranaceus and an O-methylated isoflavone. It displays a wide variety of biological activityes, including decreasing expression of pro-imflammatory cytokines, inducing apoptosis in prostate cancer cells, lowering systolic blood pressure and inhibiting attachment and motility of Giardia.
Specification
| Synonyms | Formononetol, Biochanin B; Formononetol Formononetin; NSC 93360; NSC93360; NSC-93360 |
| Storage | Store at -20°C |
| IUPAC Name | 7-hydroxy-3-(4-methoxyphenyl)chromen-4-one |
| Canonical SMILES | COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O |
| InChI | InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3 |
| InChI Key | HKQYGTCOTHHOMP-UHFFFAOYSA-N |
Properties
| Appearance | Off-white Solid |
| Application | estrogenic; antigiardial; sialidase inhibitor |
| Boiling Point | 479.4°C at 760 mmHg |
| Melting Point | 256-260°C |
| Density | 1.329 g/cm3 |
| Solubility | Soluble in DMSO |
| LogP | 3.17420 |
Reference Reading
1.Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression.
Guo YH1, Wang Y1, Xin M1. Pharm Biol. 2016 Feb 26:1-6. [Epub ahead of print]
Context Formononetin is a typical phytoestrogen, which is a bioactive component found in red clover plants. Previous studies have shown that formononetin inhibits the proliferation of several types of cancer cells, including prostate cancer and osteosarcoma. However, how formononetin affects the proliferation of CNE2 is not clear. Objective The objective of this study is to investigate the effects of formononetin on nasopharyngeal carcinoma cells in vitro, along with the underlying mechanism. Materials and methods CNE2 cells were incubated with various concentrations of formononetin (0, 0.1, 0.2, 0.3 and 1 μM) for 48 h. Cell proliferation was measured by [3-(4,5-dimethylthiazol-2-yl)]-2,5-diphenyltetrazolium bromide (MTT) assay, while the rate of apoptosis was measured by flow cytometry. Bcl-2 and bax mRNA expression levels were determined by real time polymerase chain reaction (RT-PCR), while p-ERK1/2 and bcl-2 protein expression levels were quantified by Western blotting.
2.Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression.
Guo YH1, Wang Y1, Xin M1. Pharm Biol. 2016 Feb 26:1-6. [Epub ahead of print]
Context Formononetin is a typical phytoestrogen, which is a bioactive component found in red clover plants. Previous studies have shown that formononetin inhibits the proliferation of several types of cancer cells, including prostate cancer and osteosarcoma. However, how formononetin affects the proliferation of CNE2 is not clear. Objective The objective of this study is to investigate the effects of formononetin on nasopharyngeal carcinoma cells in vitro, along with the underlying mechanism. Materials and methods CNE2 cells were incubated with various concentrations of formononetin (0, 0.1, 0.2, 0.3 and 1 μM) for 48 h. Cell proliferation was measured by [3-(4,5-dimethylthiazol-2-yl)]-2,5-diphenyltetrazolium bromide (MTT) assay, while the rate of apoptosis was measured by flow cytometry. Bcl-2 and bax mRNA expression levels were determined by real time polymerase chain reaction (RT-PCR), while p-ERK1/2 and bcl-2 protein expression levels were quantified by Western blotting.
3.Methoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions.
Mansoori MN1, Tyagi AM, Shukla P, Srivastava K, Dev K, Chillara R, Maurya R, Singh D. Menopause. 2016 May;23(5):565-76. doi: 10.1097/GME.0000000000000646.
OBJECTIVE: Recent studies have shown that immune system plays a major role in pathophysiology of postmenopausal osteoporosis. Previously we have shown that phytoestrogens like daidzein and medicarpin exhibit immunoprotective effects, by virtue of which they alleviate bone loss. With this background, methoxyisoflavones like formononetin (formo) and isoformononetin (isoformo) that have been studied for preventing bone loss in ovariectomized rats were tested for their immunomodulatory effects in estrogen-deficient bone loss mice model.
Recommended Products
| BBF-03963 | Pristinamycin | Inquiry |
| BBF-02576 | Pneumocandin B0 | Inquiry |
| BBF-03816 | Milbemycin oxime | Inquiry |
| BBF-05817 | Astaxanthin | Inquiry |
| BBF-00586 | Brefeldin A | Inquiry |
| BBF-03211 | AT-265 | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
